𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled comparison of milnacipran and fluoxetine in major depression

✍ Scribed by Marc Ansseau; Patrick Papart; Benoît Troisfontaines; Franz Bartholomé; Michel Bataille; Gérard Charles; Michel Schittecatte; Philippe Darimont; Jean-Michel Devoitille; Jules De Wilde; Michel Dufrasne; Henri Gilson; Jean-Luc Evrard; André De Nayer; Pierre Krémer; Claudine Mertens; Christiane Serre

Publisher
Springer
Year
1994
Tongue
English
Weight
686 KB
Volume
114
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled comparison of two doses of mi
Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients
✍ Marc Ansseau; Remy Frenckell; Claudine Mertens; Jules Wilde; Louis Botte; Jean-M 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 660 KB

A multicenter study compared the antidepressant efficacy and the tolerance of two doses of milnacipran (50 mg and 100 rag/day) and amitriptyline (150 rag/day) in three parallel groups of 45 major depressive inpatients defined by Research Diagnostic Criteria. After a wash-out period of 4-7 days on pl

Comparison of pramipexole, fluoxetine, a
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
✍ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Fluoxetine and sertraline dosages in maj
Fluoxetine and sertraline dosages in major depression
✍ Rowin Cantrell; William Gillespie; Lori Altshuler 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

In a retrospective study, we sought to determine medication dosages usually prescribed to obtain euthymia in 59 outpatients with a diagnosis of major depression treated with fluoxetine or sertraline. Charts of veterans admitted to the outpatient mental health clinic at the West Los Angeles Veterans

Controlled comparison of paroxetine and
Controlled comparison of paroxetine and fluvoxamine in major depression
✍ M. Ansseau; A. Gabriëls; J. Loyens; F. Bartholomé; J. L. Evrard; A. De Nayer; R. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

A multicentre study compared the antidepressant efficacy and the tolerance of two selective serotonin reuptake inhibitors, paroxetine (20-30 mg/d) and fluvoxamine (50-200 mg/d) in two parallel groups of respectively 56 and 64 patients with major depression, as defined by DSM-III-R criteria. The dura

Fluvoxamine versus fluoxetine in major d
Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison
✍ Jean Dalery; Adriaan Honig 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and

Controlled comparison of milnacipran (F2
Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients
✍ M. Ansseau; R. Von Frenckell; P. Papart; C. Mertens; J. De Wilde; L. Botte; J.-M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A multicentre study compared the antidepressant efficacy and the tolerance of milnacipran (200 mg/d) and amitriptyline (1 50 mg/d) in two parallel groups of 43 major depressive inpatients, endogenous subtype, as defined by Research Diagnostic Criteria. The duration of the study was 4 weeks, with wee